This activity is part of a curriculum titled Individualizing HIV Treatment: The Role of the Pharmacist With Addressing Racial Bias, Tolerability, and Weight Gain.
This activity is accredited for HIV/AIDs credit.
Program Description
In 2019, roughly 37,000 individuals received a new diagnosis of HIV in the United States. It is critical for antiretroviral therapy (ART) to be initiated as soon as possible after diagnosis, and measures should be taken for proper direction in care including a medication history, physical examination, laboratory evaluation, recording of specific markers, and drug-resistance testing. Pharmacists play an essential role in initiation of treatment and can assist with optimizing adherence, obtaining access to ART, and maintaining engagement. ART may also need to be modified depending on other conditions or concerns, such as blood glucose, pregnancy, metabolic issues, food insecurity, and co-infection with hepatitis B. Pharmacists are in a unique position as medication experts to provide guidance to people living with HIV. This activity will provide pharmacists with knowledge to better support people living with HIV in initial steps following diagnosis including important aspects of medication selection and monitoring of HIV treatment.
Target audience: Health-system pharmacists, retail pharmacists, and specialty pharmacists
Type of activity: Application
Release date: September 30, 2022
Expiration date: September 30, 2023
Time to complete activity: 1.0 hour
Fee: Free
Educational Objectives
At the completion of this activity, participants will be able to:
- Personalize the onboarding of a treatment-naïve person with HIV
- Explain the differences between drug-resistance testing for antiretrovirals
- Explore medication criteria to consider when choosing antiretroviral therapy in the context of specific comorbid conditions
GET STARTED WITH THIS PROGRAM:
Register now to gain access to this program.
Create AccountAlready Registered? Login Here
